Next-generation protein engineering targets influenza.
Shoshana J
SJ
Wodak
D000818:Animals; D000998:Antiviral Agents / Q000737:chemistry* / Q000494:pharmacology*; D055808:Drug Discovery / Q000379:methods*; D019267:Hemagglutinin Glycoproteins, Influenza Virus / Q000737:chemistry* / Q000378:metabolism*; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects*
D000998:Antiviral Agents; D019267:Hemagglutinin Glycoproteins, Influenza Virus